Items tagged with Access
Access expanded to improved TB diagnostics and drug susceptibility testing (post)
BD, FIND, Stop TB Partnership and UNDP collaborate to expand access to critical technology across 85 countries for improved TB diagnosis and drug susceptibility testing
Access to BD BACTEC™ MGIT™ technologies expanded to an additional 40 low- and middle-income countries
WHO Advisory Group report on Fair Pricing Forum released (post)
The report from a meeting of a World Health Organization informal advisory group on challenges of medicines pricing and organising a Fair Pricing Forum this spring has been made public. The report shows the analysis and assertions of the diverse group, as well as questions and plans to take forward.
The shifting diplomacy around migration, HIV/AIDS and TB in Central Asia (post)
Central Asia and the Russian Federation face a major intra-regional migration flow, home, as it is, to one of the largest labor migration corridors in the world, with hundreds of thousands of migrant workers moving from Central Asian countries to the Russian Federation and to Kazakhstan each year.[1] This migration flow of further concern given migrants’ increased vulnerability and poor access to HIV and TB prevention and care in host countries.
Proposed trade pact clause on intellectual property could endanger India's TB programme (post)
The latest round of the Regional Comprehensive Economic Partnership or RCEP that concluded in Japan in early March did not yield any major decisions. The stalemate is largely due to the continued insistence of developed countries to include provisions that will adversely impact generic production of cheaper medicines. If such provisions are passed, India’s tuberculosis control programme might be among the worst affected.
India: Drug to treat MDR-TB to be made available across the country (post)
New Delhi, Apr 11 (PTI) The Centre has decided to expand the availability of Bedaquiline, a drug used for treatment of drug-resistant tuberculosis, across the country, the Rajya Sabha was informed today.
India to see largest rollout of TB drugs this year (post)
Seven years after the World Health Organisation (WHO) approved guidelines to treat tuberculosis in children, India will become the largest country globally to roll out the world's first easily-dissolvable and flavoured TB drugs.
India to expand access to bedaquiline (post)
The central government has decided to increase access to Johnson & Johnson’s anti-tuberculosis drug as part of its efforts to eradicate the disease by 2025, Reuters reported on Monday. The Health Ministry’s TB division chief Sunil Kharpade said the firm’s breakthrough medicine, Bedaquiline, will be available at 140 government-run tuberculosis treatment centres.
Otsuka aims to apply for delamanid approval in India in 90 days (post)
Japanese drugmaker Otsuka Pharmaceutical aims to apply for approval of its tuberculosis (TB) drug delamanid in India within three months, a senior company official said, as calls grow for expanded access to the life-saving medicine.
Tuberculosis innovations mean little if they cannot save lives (post)
In a paper published in eLife, Madhukar Pai and Jennifer Furin summarized the uptake of new TB tools such as GeneXpert, bedaquiline and delamanid, and identified the main barriers to scale-up and patient access.
Page 28 of 83 · Total posts: 0
←First 27 28 29 Last→